Status:
COMPLETED
Transcutaneous Electrical Nerve Stimulation and Cardiac Sympathetic Overdrive in Heart Failure
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Cardiovascular Abnormalities
Eligibility:
All Genders
21-80 years
Brief Summary
Introduction: Cardiac sympathetic drive provides inotropic support to the failing heart and preserves cardiovascular homeostasis. Nonetheless, as myocardial insult evolves, this compensatory response ...
Detailed Description
Introduction: Cardiac sympathetic drive provides inotropic support to the failing heart and preserves cardiovascular homeostasis. Nonetheless, as myocardial insult evolves, this compensatory response ...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of heart failure, New York Heart Association (NYHA) functional classification between II to III and left ventricular ejection fraction ≤ 50%
Exclusion
- Regular physical activity, pregnancy, unstable angina, acute myocardial infarction in the last 6 months, pacemaker, history of chronic kidney disease (on dialysis) and cardiac surgery.
Key Trial Info
Start Date :
March 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2018
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT03354689
Start Date
March 20 2017
End Date
October 20 2018
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fabio A Alves
Niterói, CA, Brazil, 94706